Android app Apple app link

Capricor Therapeutics, Inc. (CAPR) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$28.99
Day's range
$31.4

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
05/14/2026 Roth Capital Boobalan Pachaiyappan $38.00 $29.81   27.47%
03/13/2026 Cantor Fitzgerald Kristen Kluska $62.00 $33.42   85.52%
11/11/2025 Roth Capital Boobalan Pachaiyappan $13.00 $6.20   109.68%
07/11/2025 Piper Sandler Edward Tenthoff $20.00 $7.66   161.1%
07/11/2025 H.C. Wainwright Joseph Pantginis $24.00 $7.64   214.14%
10/20/2024 Piper Sandler Edward Tenthoff $35.00 $9.43   271.16%
10/14/2024 Oppenheimer Leland Gershall $43.00 $8.89   383.69%
09/25/2024 Maxim Group Jason McCarthy $25.00 $4.55   449.45%
09/25/2024 H.C. Wainwright Joseph Pantginis $40.00 $2.78   1338.85%
09/17/2024 Oppenheimer Leland Gershall $15.00 $2.54   490.55%
05/16/2024 Oppenheimer Leland Gershall $14.00 $2.82   396.45%

Capricor Therapeutics Inc FAQ's

Capricor Therapeutics Inc has been rated by research analysts at Roth Capital, Cantor Fitzgerald, UBS, Piper Sandler, Oppenheimer, Maxim Group in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.